Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Car… — Informed

HearingSenate

Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Care System

Held

Wednesday, April 27, 2016

Held by

Senate Aging (Temporary Special) Committee

Transcript

Transcript (PDF)Transcript (HTML)

Watch / read on Congress.gov

Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Car… — Informed